Arrowhead Pharmaceuticals (Germany) Probability of Future Stock Price Finishing Under 2.68
| HDP1 Stock | EUR 18.61 1.18 5.96% |
Arrowhead |
Arrowhead Pharmaceuticals Target Price Odds to finish below 2.68
The tendency of Arrowhead Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to € 2.68 or more in 90 days |
| 18.61 | 90 days | 2.68 | near 1 |
Based on a normal probability distribution, the odds of Arrowhead Pharmaceuticals to drop to € 2.68 or more in 90 days from now is near 1 (This Arrowhead Pharmaceuticals probability density function shows the probability of Arrowhead Stock to fall within a particular range of prices over 90 days) . Probability of Arrowhead Pharmaceuticals price to stay between € 2.68 and its current price of €18.61 at the end of the 90-day period is about 39.75 .
Assuming the 90 days trading horizon Arrowhead Pharmaceuticals has a beta of 0.99. This usually indicates Arrowhead Pharmaceuticals market returns are reactive to returns on the market. As the market goes up or down, Arrowhead Pharmaceuticals is expected to follow. Additionally Arrowhead Pharmaceuticals has an alpha of 0.0581, implying that it can generate a 0.0581 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Arrowhead Pharmaceuticals Price Density |
| Price |
Predictive Modules for Arrowhead Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Arrowhead Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Arrowhead Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Arrowhead Pharmaceuticals is not an exception. The market had few large corrections towards the Arrowhead Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Arrowhead Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Arrowhead Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.06 | |
β | Beta against Dow Jones | 0.99 | |
σ | Overall volatility | 2.24 | |
Ir | Information ratio | 0.01 |
Arrowhead Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Arrowhead Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Arrowhead Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Arrowhead Pharmaceuticals had very high historical volatility over the last 90 days | |
| Arrowhead Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 243.23 M. Net Loss for the year was (176.06 M) with profit before overhead, payroll, taxes, and interest of 243.23 M. | |
| Arrowhead Pharmaceuticals has accumulated about 218.2 M in cash with (136.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.3. | |
| Roughly 69.0% of the company shares are owned by institutional investors |
Arrowhead Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Arrowhead Stock often depends not only on the future outlook of the current and potential Arrowhead Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Arrowhead Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 106 M |
Arrowhead Pharmaceuticals Technical Analysis
Arrowhead Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Arrowhead Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Arrowhead Pharmaceuticals. In general, you should focus on analyzing Arrowhead Stock price patterns and their correlations with different microeconomic environments and drivers.
Arrowhead Pharmaceuticals Predictive Forecast Models
Arrowhead Pharmaceuticals' time-series forecasting models is one of many Arrowhead Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Arrowhead Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Arrowhead Pharmaceuticals
Checking the ongoing alerts about Arrowhead Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Arrowhead Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Arrowhead Pharmaceuticals had very high historical volatility over the last 90 days | |
| Arrowhead Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 243.23 M. Net Loss for the year was (176.06 M) with profit before overhead, payroll, taxes, and interest of 243.23 M. | |
| Arrowhead Pharmaceuticals has accumulated about 218.2 M in cash with (136.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.3. | |
| Roughly 69.0% of the company shares are owned by institutional investors |
Additional Information and Resources on Investing in Arrowhead Stock
When determining whether Arrowhead Pharmaceuticals is a strong investment it is important to analyze Arrowhead Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Arrowhead Pharmaceuticals' future performance. For an informed investment choice regarding Arrowhead Stock, refer to the following important reports:Check out Arrowhead Pharmaceuticals Backtesting, Arrowhead Pharmaceuticals Valuation, Arrowhead Pharmaceuticals Correlation, Arrowhead Pharmaceuticals Hype Analysis, Arrowhead Pharmaceuticals Volatility, Arrowhead Pharmaceuticals History as well as Arrowhead Pharmaceuticals Performance. For more detail on how to invest in Arrowhead Stock please use our How to Invest in Arrowhead Pharmaceuticals guide.You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.